blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2471810

EP2471810 - Oxyntomodulin derivatives [Right-click to bookmark this link]
StatusThe application has been withdrawn
Status updated on  05.04.2013
Database last updated on 13.09.2024
Most recent event   Tooltip05.04.2013Withdrawal of applicationpublished on 08.05.2013  [2013/19]
Applicant(s)For all designated states
Merck Sharp & Dohme Corp.
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
For all designated states
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A.
Via Pontina KM. 30, 600
00040 Pomezia / IT
[N/P]
Former [2012/33]For all designated states
Merck Sharp & Dohme Corp.
126 East Lincoln Avenue
Rahway NJ 07065-0907 / US
For all designated states
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A.
Via Pontina KM. 30, 600
00040 Pomezia / IT
Former [2012/27]For all designated states
Schering Corporation
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
For all designated states
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A.
Via Pontina KM. 30, 600
00040 Pomezia / IT
Inventor(s)01 / Roy, Ranabir Sinha
Merck Sharp & Dohme Corp.
126 East Lincoln Avenue
Rahway, NJ New Jersey 07065-0907 / US
02 / Bianchi, Elisabetta
IRBM
Via Pontina Km 30.600
Pomezia
i-00040 Rome / IT
03 / Pessi, Antonello
IRBM
Via Pontina Km 30.600
Pomezia
i-00040 Rome / IT
04 / Ingallinella, Paolo
IRBM
Via Pontina Km 30.600
Pomezia
i-00040 Rome / IT
05 / Marsh, Donald, J.
Merck Sharp & Dohme Corp.
126 East Lincoln Avenue
Rahway, NJ New Jersey 07065-0907 / US
06 / Eiermann, George, J.
Merck Sharp & Dohme Corp.
126 East Lincoln Avenue
Rahway, NJ New Jersey 07065-0907 / US
07 / Mu, YingJun
Merck Sharp & Dohme Corp.
126 East Lincoln Avenue
Rahway, NJ New Jersey 07065-0907 / US
08 / Zhou, Yin-Ping
Merck Sharp & Dohme Corp.
126 East Lincoln Avenue
Rahway, NJ New Jersey 07065-0907 / US
 [2012/27]
Representative(s)Horgan, James Michael Frederic, et al
Merck Sharp & Dohme Corp.
120 Moorgate
London, EC2M 6UR / GB
[N/P]
Former [2012/27]Horgan, James Michael Frederic, et al
Merck & Co., Inc. European Patent Department Hertford Road Hoddesdon
EN11 9BU / GB
Application number, filing date12159697.716.02.2007
[2012/27]
Priority number, dateUS20060775544P22.02.2006         Original published format: US 775544 P
US20060834452P31.07.2006         Original published format: US 834452 P
[2012/27]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2471810
Date:04.07.2012
Language:EN
[2012/27]
Search report(s)(Supplementary) European search report - dispatched on:EP04.06.2012
ClassificationIPC:C07K14/575, A61K38/00
[2012/27]
CPC:
A61P3/00 (EP); C07K14/575 (US); A61P3/04 (EP);
A61P3/08 (EP); A61P3/10 (EP); C07K14/605 (EP);
A61K38/00 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2012/27]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
RSNot yet paid
TitleGerman:Oxyntomodulinderivate[2012/27]
English:Oxyntomodulin derivatives[2012/27]
French:Dérivés d'oxyntomoduline[2012/27]
Examination procedure04.01.2013Examination requested  [2013/08]
12.02.2013Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time
04.04.2013Application withdrawn by applicant  [2013/19]
Parent application(s)   TooltipEP07751091.5  / EP1991574
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20070751091) is  15.03.2010
Fees paidRenewal fee
16.07.2012Renewal fee patent year 03
16.07.2012Renewal fee patent year 04
16.07.2012Renewal fee patent year 05
16.07.2012Renewal fee patent year 06
07.02.2013Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[E]WO2007056362  (UNIV INDIANA RES & TECH CORP [US], et al) [E] 1-12 * sequences 25, 33, 39 *;
 [XP]WO2006134340  (IMP INNOVATIONS LTD [GB], et al) [XP] 1-12 * the whole document * * pages 115-128 * * claim 36 *;
 [X]WO2004062685  (IMP COLLEGE INNOVATIONS LTD [GB], et al) [X] 1-12 * the whole document * * sequence 1 *;
 [A]WO0183527  (AMGEN INC [US]) [A] 1-12 * the whole document * * table 1 *
 [A]  - HINKE SIMON AMADEUS ET AL, "Dipeptidyl peptidase IV (DPIV/CD26) degradation of glucagon: Characterization of glucagon degradation products and DPIV-resistant analogs", JOURNAL OF BIOLOGICAL CHEMISTRY, (20000211), vol. 275, no. 6, ISSN 0021-9258, pages 3827 - 3834, XP002445664 [A] 1-12 * the whole document * * figure 7 *

DOI:   http://dx.doi.org/10.1074/jbc.275.6.3827
by applicantUS5932462
 WO03077847
 WO2005000809
    - DAKIN ET AL., ENDOCRINOLOGY, (2001), vol. 142, pages 4244 - 4250
    - DAKIN ET AL., ENDOCRINOLOGY, (2004), vol. 145, pages 2687 - 2695
    - DAKIN ET AL., AM. JPHYSIOL. ENDOCRINOL. METAB., (2002), vol. 283, pages E1173 - E1177
    - CARLES-BONNET ET AL., PEPTIDES, (1996), vol. 17, pages 557 - 561
    - COHEN ET AL., J CLIN. ENDOCRINOL. METAB., (2003), vol. 88, pages 4696 - 4701
    - WYNNE ET AL., DIABETES, (2005), vol. 54, pages 2390 - 2395
    - LOTTE, B. K., J MED. CHEM., (2004), vol. 47, pages 4128 - 4134
    - PENNINGTON; DUNN, PEPTIDE SYNTHESIS PROTOCOLS, (1994), vol. 35
    - JARROUSSE ET AL., ENDOCRINOLOGY, (1984), vol. 115, pages 102 - 105
    - RINK, H., TETRAHEDRON LETT., (1987), vol. 28, pages 3787 - 3789
    - BERNATOWICZ, M. S. ET AL., TETRAHEDRON LETT., (1989), vol. 30, pages 4645 - 4667
    - SOLE, N. A.; G. BARANY, J ORG. CHEM., (1992), vol. 57, pages 5399 - 5403
    - CASCIERI ET AL., J. BIOL. CHEM., (1999), vol. 274, pages 8694 - 8697
    - MINAMI K ET AL., "2000", AM J PHYSIOL ENDOCRINOL METAB., vol. 279, pages E773 - E781
    - LACY ET AL., DIABETES, (1967), vol. 16, pages 35 - 39
    - ZHOU ET AL., J. BIOL. CHEM., (2003), vol. 278, pages 51316 - 51323
    - SCROCCHI LA ET AL., NAT MED, (1996), vol. 2, pages 1254 - 1258
    - GELLING, XQ ET AL., PROC. NATL. ACAD. SCI. U. S. A., (2003), vol. 100, pages 1438 - 1443
    - THORENS, B ET AL., DIABETES, (1993), vol. 42, pages 1678 - 1682
 US20030530867
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.